Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Condition:   Lymphoma Interventions:   Drug: PEG-rhG-CSF;   Drug: RhG-CSF Sponsors:   Chongqing University Cancer Hospital;   CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions:   B-Cell Non Hodgkin Lymphoma;   B-Cell Acute Lymphoblastic Leukemia Intervention:   Biological: anti-CD19 CAR T-cells Sponsors:   Vinmec Research Institute of Stem Cell and Gene Technology;   National Institute of Hematology and Blood Transfusion, Vietnam Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Condition:   Lymphoma Interventions:   Drug: PEG-rhG-CSF;   Drug: RhG-CSF Sponsors:   Chongqing University Cancer Hospital;   CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions:   B-Cell Non Hodgkin Lymphoma;   B-Cell Acute Lymphoblastic Leukemia Intervention:   Biological: anti-CD19 CAR T-cells Sponsors:   Vinmec Research Institute of Stem Cell and Gene Technology;   National Institute of Hematology and Blood Transfusion, Vietnam Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Condition:   Lymphoma Interventions:   Drug: PEG-rhG-CSF;   Drug: RhG-CSF Sponsors:   Chongqing University Cancer Hospital;   CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions:   B-Cell Non Hodgkin Lymphoma;   B-Cell Acute Lymphoblastic Leukemia Intervention:   Biological: anti-CD19 CAR T-cells Sponsors:   Vinmec Research Institute of Stem Cell and Gene Technology;   National Institute of Hematology and Blood Transfusion, Vietnam Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Condition:   Lymphoma Interventions:   Drug: PEG-rhG-CSF;   Drug: RhG-CSF Sponsors:   Chongqing University Cancer Hospital;   CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions:   B-Cell Non Hodgkin Lymphoma;   B-Cell Acute Lymphoblastic Leukemia Intervention:   Biological: anti-CD19 CAR T-cells Sponsors:   Vinmec Research Institute of Stem Cell and Gene Technology;   National Institute of Hematology and Blood Transfusion, Vietnam Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Condition:   Lymphoma Interventions:   Drug: PEG-rhG-CSF;   Drug: RhG-CSF Sponsors:   Chongqing University Cancer Hospital;   CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions:   B-Cell Non Hodgkin Lymphoma;   B-Cell Acute Lymphoblastic Leukemia Intervention:   Biological: anti-CD19 CAR T-cells Sponsors:   Vinmec Research Institute of Stem Cell and Gene Technology;   National Institute of Hematology and Blood Transfusion, Vietnam Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Condition:   Lymphoma Interventions:   Drug: PEG-rhG-CSF;   Drug: RhG-CSF Sponsors:   Chongqing University Cancer Hospital;   CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions:   B-Cell Non Hodgkin Lymphoma;   B-Cell Acute Lymphoblastic Leukemia Intervention:   Biological: anti-CD19 CAR T-cells Sponsors:   Vinmec Research Institute of Stem Cell and Gene Technology;   National Institute of Hematology and Blood Transfusion, Vietnam Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials